Paxman AB (publ)
Paxman AB (publ) (PXMBF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Paxman AB (publ) (PXMBF), featuring income statements, balance sheets, and cash flow data.
Paxman AB (publ) (PXMBF) Income Statement & Financial Overview
Analyze Paxman AB (publ)’s PXMBF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $67.13M | $66.15M | $64.82M | $63.41M |
| Cost of Revenue | $22.60M | $20.09M | $20.66M | $52.81M |
| Gross Profit | $44.53M | $46.06M | $44.16M | $10.60M |
| Gross Profit Ratio | $0.66 | $0.70 | $0.68 | $0.17 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $18.40M | $18.83M | $17.25M | $16.88M |
| Operating Expenses | $38.33M | $39.06M | $35.67M | $34.10M |
| Total Costs & Expenses | $60.93M | $59.15M | $56.33M | $52.81M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $11.72M | $316000.00 | $3.44M | $763000.00 |
| Depreciation & Amortization | $4.18M | $4.46M | $3.26M | $4.17M |
| EBITDA | $10.38M | $18.26M | $11.76M | $14.77M |
| EBITDA Ratio | $0.15 | $0.28 | $0.18 | $0.23 |
| Operating Income | $6.20M | $7.003M | $8.50M | $10.60M |
| Operating Income Ratio | $0.09 | $0.11 | $0.13 | $0.17 |
| Other Income/Expenses (Net) | -$11.73M | $6.48M | -$3.44M | -$763000.00 |
| Income Before Tax | -$5.53M | $13.49M | $5.06M | $9.84M |
| Income Before Tax Ratio | -$0.08 | $0.20 | $0.08 | $0.16 |
| Income Tax Expense | -$17000.00 | $1.30M | $65000.00 | $21000.00 |
| Net Income | -$5.51M | $12.18M | $5.00M | $9.82M |
| Net Income Ratio | -$0.08 | $0.18 | $0.08 | $0.15 |
| EPS | -$0.29 | $0.64 | $0.26 | $0.52 |
| Diluted EPS | -$0.29 | $0.64 | $0.26 | $0.51 |
| Weighted Avg Shares Outstanding | $19.25M | $19.01M | $19.01M | $19.01M |
| Weighted Avg Shares Outstanding (Diluted) | $19.32M | $19.08M | $19.08M | $19.08M |
Over the past four quarters, Paxman AB (publ) demonstrated steady revenue growth, increasing from $63.41M in Q2 2024 to $67.13M in Q1 2025. Operating income reached $6.20M in Q1 2025, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $10.38M, reflecting operational efficiency. Net income dropped to -$5.51M, with EPS at -$0.29. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan